A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups

A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups

Author Scrideli, Carlos A. Google Scholar
Assumpcao, Juliana G. Google Scholar
Ganazza, Monica A. Google Scholar
Araujo, Marcela Google Scholar
Toledo, Silvia Regina Caminada de Autor UNIFESP Google Scholar
Lee, Maria Lúcia Martino Autor UNIFESP Google Scholar
Delbuono, Elisabete Autor UNIFESP Google Scholar
Petrilli, Antonio Sergio Autor UNIFESP Google Scholar
Queiroz, Rosane R. Google Scholar
Biondi, Andrea Google Scholar
Viana, Marcos B. Google Scholar
Yunes, Jose A. Google Scholar
Brandalise, Silvia R. Google Scholar
Tone, Luiz G. Google Scholar
Institution Universidade de São Paulo (USP)
Ctr Infantil Boldrini
Universidade Federal de São Paulo (UNIFESP)
Univ Milano Bicocca
Universidade Federal de Minas Gerais (UFMG)
Abstract BackgroundMinimal residual disease is an important independent prognostic factor in childhood acute lymphoblastic leukemia. the classical detection methods such as multiparameter flow cytometry and real-time quantitative polymerase chain reaction analysis are expensive, time-consuming and complex, and require considerable technical expertise.Design and MethodsWe analyzed 229 consecutive children with acute lymphoblastic leukemia treated according to the GBTLI-99 protocol at three different Brazilian centers. Minimal residual disease was analyzed in bone marrow samples at diagnosis and on days 14 and 28 by conventional homo/heteroduplex polymerase chain reaction using a simplified approach with consensus primers for IG and TCR gene rearrangements.ResultsAt least one marker was detected by polymerase chain reaction in 96.4%, of the patients. By combining the minimal residual disease results obtained on days 14 and 28, three different prognostic groups were identified: minimal residual disease negative on days 14 and 28, positive on day 14/negative on day 28, and positive on both. Five-year event-free survival rates were 85%, 75.6%,, and 27.8%, respectively (p<0.0001). the same pattern of stratification held true for the group of intensively treated children. When analyzed in other subgroups of patients such as those at standard and high risk at diagnosis, those with positive B-derived CD10, patients positive for the TEL/AML1 transcript, and patients in morphological remission on a day 28 marrow, the event-free survival rate was found to be significantly lower in patients with positive minimal residual disease on day 28. Multivariate analysis demonstrated that the detection of minimal residual disease on day 28 is the most significant prognostic factor.ConclusionsThis simplified strategy for detection of minimal residual disease was feasible, reproducible, cheaper and simpler when compared with other methods, and allowed powerful discrimination between children with acute lymphoblastic leukemia with a good and poor outcome.
Keywords minimal residual disease
acute lymphoblastic leukemia
childhood
IG
TCR
Language English
Sponsor Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
Grant number FAPESP: 2005/02279-6
Date 2009-06-01
Published in Haematologica-the Hematology Journal. Pavia: Ferrata Storti Foundation, v. 94, n. 6, p. 781-789, 2009.
ISSN 0390-6078 (Sherpa/Romeo, impact factor)
Publisher Ferrata Storti Foundation
Extent 781-789
Origin http://dx.doi.org/10.3324/haematol.2008.003137
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000267325200010
URI http://repositorio.unifesp.br/handle/11600/31539

Show full item record




File

Name: WOS000267325200010.pdf
Size: 242.7Kb
Format: PDF
Description:
Open file

This item appears in the following Collection(s)

Search


Browse

Statistics

My Account